Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Jan. 30, 2021   233,400,000      
Beginning balance at Jan. 30, 2021 $ 7,285.3 $ 2.3 $ 2,138.5 $ (35.2) $ 5,179.7
Statement of Stockholders' Equity [Roll Forward]          
Net income 374.5       374.5
Total other comprehensive income (loss) 5.0     5.0  
Issuance of stock under Employee Stock Purchase Plan (in shares)   100,000      
Issuance of stock under Employee Stock Purchase Plan 3.8   3.8    
Exercise of stock options (in shares)   0      
Exercise of stock options 0.2   0.2    
Stock-based compensation, net (in shares)   500,000      
Stock-based compensation, net $ (7.5)   (7.5)    
Repurchase of stock (in shares) (2,150,572) (2,200,000)      
Repurchase of stock $ (250.0) $ 0.0 (250.0)    
Ending balance (in shares) at May. 01, 2021   231,800,000      
Ending balance at May. 01, 2021 7,411.3 $ 2.3 1,885.0 (30.2) 5,554.2
Beginning balance (in shares) at Jan. 29, 2022   225,100,000      
Beginning balance at Jan. 29, 2022 7,718.5 $ 2.2 1,243.9 (35.2) 6,507.6
Statement of Stockholders' Equity [Roll Forward]          
Net income 536.4       536.4
Total other comprehensive income (loss) (0.1)     (0.1)  
Issuance of stock under Employee Stock Purchase Plan (in shares)   0      
Issuance of stock under Employee Stock Purchase Plan $ 2.9   2.9    
Exercise of stock options (in shares) 370        
Stock-based compensation, net (in shares)   500,000      
Stock-based compensation, net $ (2.0)   (2.0)    
Repurchase of stock (in shares) (89,779) (100,000)      
Repurchase of stock $ (14.2) $ 0.0 (14.2)    
Ending balance (in shares) at Apr. 30, 2022   225,500,000      
Ending balance at Apr. 30, 2022 $ 8,241.5 $ 2.2 $ 1,230.6 $ (35.3) $ 7,044.0